Concerns regarding the use of antenatal betamethasone in late preterm gestation: is the evidence of potential harm being overstated?
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, Columbia University, New York, NY, USA.
C
C
Gyamfi-Bannerman
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Texas Medical Branch at Galveston, Galveston, TX, USA.
G
G
Saade
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, McGovern Medical School-University of Texas at Houston, Houston, TX, USA.
S C
SC
Blackwell
D001623:Betamethasone; D055317:Evidence-Based Practice; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D047928:Premature Birth
D005938:Glucocorticoids; D001623:Betamethasone